ArticleThorax2015
The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study.
Article in Thorax, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.
- Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.Thorax · 2022Pooled it
- Pooled it
- Factors Explaining Socio-Economic Inequalities in Cancer Survival: A Systematic Review.Cancer control : journal of the Moffitt Cancer CenterPooled it
- Development and internal validation of a prognostic model for cancer-specific survival in elderly patients with metastatic non-small cell lung cancer: a SEER-based study.Journal of thoracic disease · 2026Article
- Diagnostic intervals and imaging use in lung cancer: a national real-world study in England.BMJ open respiratory research · 2026Article
- Evaluating the Time Interval Between Symptoms Onset, Diagnosis, and Therapeutic Intervention in Lung Cancer: A Cross-Sectional Study in Southern Iran.Cancer reports (Hoboken, N.J.) · 2024Article
- Understanding the impact of distance and disadvantage on lung cancer care and outcomes: a study protocol.BMC cancer · 2024Article
- A taxonomy of early diagnosis research to guide study design and funding prioritisation.British journal of cancer · 2023Review
- Machine Learning Techniques to Predict Timeliness of Care among Lung Cancer Patients.Healthcare (Basel, Switzerland) · 2023Article
- The promises and challenges of early non-small cell lung cancer detection: patient perceptions, low-dose CT screening, bronchoscopy and biomarkers.Molecular oncology · 2021Review
- Reducing health inequalities through general practice: protocol for a realist review (EQUALISE).BMJ open · 2021Article
- Are socio-economic inequalities in breast cancer survival explained by peri-diagnostic factors?BMC cancer · 2021Article
- Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis.PloS one · 2021Article
- Observational
- How long is too long? A scoping review of health system delays in lung cancer.European respiratory review : an official journal of the European Respiratory Society · 2018Article
- Socioeconomic Differences and Lung Cancer Survival-Systematic Review and Meta-Analysis.Frontiers in oncology · 2018Article
- Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomes.Current oncology (Toronto, Ont.) · 2017Article
- Medical complexity and time to lung cancer treatment - a three-year retrospective chart review.BMC health services research · 2017Article
- Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).PloS one · 2017Article
- Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundLung cancer survival is socioeconomically patterned, and socioeconomic inequalities in receipt of treatment have been demonstrated. In England, there are target waiting times for the referral (14 days) and treatment intervals (31 days from diagnosis, 62 days from GP referral). Socioeconomic inequalities in the time intervals from GP referral have been found. Cancer registry, Hospital Episode Statistics and lung cancer audit data were linked in order to investigate the contribution of these inequalities to socioeconomic inequalities in lung cancer survival.
methodsLogistic regression was used to examine the likelihood of being alive 2 years after diagnosis, by socioeconomic position, for 22,967 lung cancer patients diagnosed in 2006-2009, and in a subset with stage recorded (n=5233).
resultsSocioeconomic inequalities in survival were found in a multivariable analysis adjusted for age, sex, histology, year, timely GP referral, performance status and comorbidity, with those in the most deprived socioeconomic group significantly less likely to be alive after 2 years (OR=0.77, 95% CI 0.66 to 0.88, p<0.001). When receipt of treatment was included in the analysis, the association no longer remained significant (OR=0.87, 95% CI 0.75 to 1.00, p=0.06). Addition of timeliness of treatment did not alter the conclusion. Patients treated within guideline targets had lower likelihood of two-year survival.
conclusionsSocioeconomic inequalities in survival from lung cancer were statistically explained by socioeconomic inequalities in receipt of treatment, but not by timeliness of referral and treatment. Further research is required to determine the currently unexplained socioeconomic variance in treatment rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.